DNA sequencing has undergone a revolution in recent years, where the introduction of new technologies have led to dramatic increases in our capacity to sequence DNA and related molecules. As a result, we now have the ability to study genetic factors in human disease at an unprecedented scale. These developments have huge relevance for neurological disorders as we now appreciate that genetic changes are characteristic of many individual cases. For example, around 30% of devastating childhood epilepsies have an identifiable genetic cause.
FutureNeuro is working to extend our knowledge of the genetics of neurological disorders via the application of so called ‘next generation’ sequencing techniques to specific patient groups, who perhaps have been diagnosed with certain types of epilepsy, or have responded in a particular way to treatment.
We believe the potential value of DNA sequence goes far diagnosis, and through FutureNeuro we want to see clinical sequencing informing on prognosis and treatment.